MedPath

Comparing the effect of focused stimulation and enhanced milieu teaching (mand-model strategy) late-talking toddlers.

Not Applicable
Recruiting
Conditions
ate talker.
Expressive language disorder
F80.1
Registration Number
IRCT20230812059124N1
Lead Sponsor
Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
4
Inclusion Criteria

Having a delay in the development of expressive language
Between the ages of 18 and 36 months
Being monolingual in Persian
Not having non-verbal cognitive problems
Not having hearing and vision defects and emotional behavioral problems (psychiatry)
Not having oral-motor defects (structural and functional)
The mean length of the child's utterances is between 1 and 3.5
Have at least 10 expressive words
Having the ability to imitate words

Exclusion Criteria

The unwillingness of the family to cooperate or to carry out further evaluations during the stages of longitudinal examination of the child
The patient should use other speech therapy services at the same time as the research
The child suffering from convulsions or diseases during the study that lead to vision, hearing, neuro-motor or permanent structural problems.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expression of trained words with each of the treatment methods. Timepoint: At the beginning of all three stages of the study (baseline, intervention, withdrawal), at the beginning of each session, the ability of the child with late speech to express therapeutic words is measured for each method. Method of measurement: Name the object or image of each word.
Secondary Outcome Measures
NameTimeMethod
Expression of untrained words. Timepoint: At the beginning of the baseline phase and once every 3 sessions in the intervention phase and in the withdrawal phase. Method of measurement: Name the object or image of each word.
© Copyright 2025. All Rights Reserved by MedPath